Advertising in the International Journal Clinical Rhinology: A Practical Guide to AIJCR Magazine Advertising in India for Pharma and Medical Device Brands

Most pharmaceutical marketing teams we speak with have never considered the International Journal Clinical Rhinology as an advertising channel — and that, frankly, is a significant missed opportunity. The journal reaches a concentrated audience of ENT surgeons, rhinologists, and otolaryngology specialists across India, which means that every rupee spent on clinical rhinology journal advertising is working harder than a generalist medical publication could ever manage. When you factor in the peer-reviewed credibility that comes from being associated with the All India Rhinology Society, the case for including AIJCR in your HCP outreach India strategy becomes difficult to ignore.

What Is the International Journal Clinical Rhinology and Who Publishes It in India?

The AIJCR — formally titled An International Journal Clinical Rhinology — is the official peer-reviewed publication of the All India Rhinology Society, which is the premier professional body for rhinologists and ENT surgeons with a subspecialty interest in nasal and sinus conditions across India. Published by Jaypee Brothers Medical Publishers (P) Ltd, one of the most respected names in Indian medical publishing, the journal carries the print ISSN 0974-4630 and eISSN 0975-6965, and it appears as a tri-annual publication — meaning three issues per year, which gives advertisers a structured, predictable calendar to plan campaigns around. The journal is indexed in Embase, which is a distinction that matters enormously to the scientific community and, by extension, to the credibility your brand earns by appearing alongside that content.

What a lot of people miss is that Jaypee Brothers Medical Publishers operates both a traditional print distribution network and the JaypeeDigital platform, which hosts the full digital archive of the journal and serves as the gateway for online access; this dual-channel presence means that an advertisement placed in the international journal clinical rhinology can reach readers both through physical copies distributed to AIRS members and through digital access on JaypeeDigital. The journal is also preserved through Portico, the digital preservation service, and is aligned with COPE (Committee on Publication Ethics) standards — details that signal the publication's seriousness to any advertiser conducting due diligence. Content is published under Creative Commons CC BY-NC 4.0 licensing, which governs how articles are shared, though advertising placements operate under separate commercial terms negotiated directly with the publisher.

At SmartAds, we always tell our clients that the publisher relationship matters as much as the placement itself; Jaypee Brothers Medical Publishers has decades of experience managing pharmaceutical company advertising within Indian medical journals, which means the production, compliance, and distribution infrastructure is genuinely professional rather than ad hoc. Their New Delhi, India headquarters coordinates both the editorial and commercial operations of the journal, and Jaypee journals advertisement booking is handled through a dedicated commercial team — something we will walk through in detail later in this piece.

Why Should Pharma Brands Advertise in the Clinical Rhinology Journal?

Specificity is the single most undervalued quality in medical journal advertising, and the international journal clinical rhinology delivers it in a way that broader ENT journals simply cannot. A pharmaceutical company advertising a nasal corticosteroid, an antihistamine, or a biologic for chronic rhinosinusitis is not wasting impressions on cardiologists or dermatologists; every reader of this journal is, by professional definition, someone who writes prescriptions for exactly the conditions these products treat. That kind of targeted medical outreach is extraordinarily difficult to replicate through digital channels alone, where even the most sophisticated HCP-targeted programmatic campaigns suffer from audience leakage and verification challenges.

The prescribing behavior influence that a peer-reviewed journal carries is something that has been studied extensively — and the findings consistently show that physicians trust information encountered in indexed medical journals more than they trust promotional materials received through other channels. When your brand appears in the international journal clinical rhinology, it is not just occupying advertising space; it is being seen in the same context as rhinology research India's most active specialists are reading to update their clinical practice. One pharmaceutical client we worked with — a company launching a new nasal drug delivery device — told us that their field force reported significantly warmer reception from ENT specialists who had already seen the product featured in the journal, which is a qualitative signal that is hard to quantify but impossible to dismiss.

On top of that, the cost-effective journal advertising argument holds up well when you compare the CPM against other HCP outreach channels. A full page advertisement in a specialty rhinology journal India publication reaches somewhere in the ballpark of several thousand verified healthcare professionals — ENT surgeons India, rhinologists, postgraduate ENT India trainees, and allied specialists — at a cost per verified HCP contact that is genuinely competitive with digital alternatives, which often struggle to confirm that the person clicking is actually a practising clinician. The FICCI-EY Media and Entertainment Report has consistently highlighted the resilience of specialist print media in professional and B2B contexts, even as consumer print has faced headwinds; medical journal advertising in India sits squarely in that resilient category.

What Are the Print Advertising Options Available in AIJCR?

The print advertising options in the international journal clinical rhinology follow the standard premium-position hierarchy that experienced media planners will recognise immediately. The back cover advertisement is the most premium position available — it is the placement that gets seen every time a copy is picked up, set down, or passed across a table, which makes it the default recommendation for product launches or brand-awareness campaigns where visibility frequency matters more than deep engagement. The inside front cover ad is the second-most-coveted position, offering right-hand-page prominence immediately upon opening the journal, which is a placement that tends to perform well for campaigns where the creative is designed to stop a reader before they reach the contents page.

Beyond the premium covers, the journal accommodates full page advertisements throughout the body of the publication, as well as half page advertisement options for brands working with tighter budgets or for campaigns where the creative concept works at a smaller scale. To be honest, we have seen half page advertisement placements outperform full page options when the creative is exceptionally well-executed and the message is tight — the size of the placement matters less than the relevance of the message to the reader, and in a specialist journal like AIJCR, readers are paying close attention to everything on the page. Print advertising medical journal placements in AIJCR are produced in CMYK colour, and artwork should be submitted at a minimum resolution of 300 DPI with bleed dimensions following Jaypee Brothers' standard specifications, which their commercial team provides upon booking confirmation.

What we tell our clients when planning print advertising medical journal campaigns is to think in terms of the full three-issue annual cycle rather than a single insertion. A brand that appears across all three issues of a tri-annual publication builds a familiarity with the readership that a one-time placement simply cannot achieve; the rhinologist who sees your product in the January issue, again in May, and again in September is far more likely to associate your brand with clinical authority than one who encountered a single advertisement months ago. Journal advertising rates for multi-issue bookings are typically negotiable, and Jaypee Brothers Medical Publishers has historically been open to package discussions for committed annual advertisers — something that SmartAds facilitates directly on behalf of our clients.

How Does Digital Advertising Work in the Clinical Rhinology Journal?

The digital advertising dimension of AIJCR is an area where we have found most brands are genuinely uninformed, partly because there is very little published information about it and partly because the journal's digital presence has grown more sophisticated than most advertisers realise. Through the JaypeeDigital platform, which hosts the full text of the international journal clinical rhinology, there are opportunities for banner ad journal placements that appear alongside article pages — meaning your advertisement is seen by a reader who is actively engaged with rhinology research content, which is arguably the highest-quality context a medical device advertising or pharmaceutical company advertising campaign can occupy. These are not passive impressions; they are served to someone who has specifically navigated to a rhinology article.

The e-TOC alert advertising option is one that we consider genuinely underutilised in the Indian market. When a new issue of the international journal clinical rhinology is published, subscribers and registered users receive an electronic Table of Contents alert — and that email, which goes to verified healthcare professionals who have opted in to receive journal updates, represents a highly targeted digital touchpoint. An advertisement or sponsored message embedded within an e-TOC alert reaches doctors at the precise moment they are engaging with new clinical content, which is a context that no social media platform or programmatic network can replicate. Digital advertising journal placements of this type tend to have smaller absolute reach numbers than mass digital channels, but the quality of that reach — verified ENT specialists, rhinologists, and otolaryngology practitioners — is exceptional.

Frankly speaking, the digital advertising options in Indian specialty journals like AIJCR are still maturing, and the open access journal model that AIJCR follows under Creative Commons CC BY-NC 4.0 means that article content is more widely distributed than it would be behind a paywall — which expands the potential audience for digital ad placements beyond just paid subscribers. At SmartAds, we have helped medical device advertising clients combine print insertions with digital banner placements on JaypeeDigital to create a surround-sound effect that reinforces brand messaging across both the physical and digital reading experience; the results, in terms of brand recall among ENT surgeons India, have been meaningfully better than either channel alone.

Who Is the Target Audience of the AIJCR Magazine in India?

The readership of the international journal clinical rhinology is, by design, one of the most precisely defined audiences in Indian medical publishing. The primary readers are members of the All India Rhinology Society — AIRS — which encompasses practising rhinologists, ENT surgeons with a subspecialty focus on nasal and sinus conditions, skull base surgery specialists, and otolaryngology faculty at medical colleges across India. This is not a general ENT audience; it skews heavily towards specialists who are actively performing nasal sinus surgery, managing chronic rhinosinusitis, and treating conditions that sit at the intersection of otolaryngology and skull base surgery — which makes it a remarkably precise channel for brands whose products address those clinical areas.

Beyond the AIRS membership core, the journal also reaches postgraduate ENT India trainees — DNB and MS students in otolaryngology — who are at the stage of forming their clinical habits and brand associations, which is something that pharmaceutical marketing teams often overlook when thinking about long-term prescribing behavior influence. A resident who encounters your brand in a peer-reviewed journal during their training years carries that association into independent practice; we have seen this dynamic play out across multiple campaigns, and it consistently justifies the investment in indexed medical journal advertising even when the immediate prescriber universe seems small. The readership also includes allied healthcare professionals, medical device procurement officers in ENT departments, and hospital administrators who read the journal for clinical intelligence.

In terms of geographic spread, AIRS membership and AIJCR readership are concentrated in major metros — Delhi, Mumbai, Bengaluru, Chennai, Hyderabad — but the journal's reach extends meaningfully into tier-2 cities where ENT specialists are building practices and are, if anything, less saturated with pharmaceutical marketing than their metro counterparts. Advertise to doctors India campaigns that ignore this tier-2 dimension are, in our experience, leaving significant brand-building opportunity on the table; the international journal clinical rhinology, distributed through Jaypee Brothers Medical Publishers' national network, reaches these practitioners in a way that field force visits often do not.

What Are the Advertising Policy and Eligibility Rules for AIJCR?

The editorial independence of the international journal clinical rhinology is protected by a clear separation between the editorial team — which operates under AIRS academic governance — and the commercial advertising function managed by Jaypee Brothers Medical Publishers. This is not merely a formality; it is a structural commitment that aligns with ICMJE guidelines, which specify that advertising must not influence editorial decisions and that the journal must be willing to publish studies that reflect negatively on advertised products. Advertisers who understand this framework actually benefit from it, because the credibility that editorial independence confers on the journal is precisely what makes an advertisement appearing in its pages carry more weight with readers.

Advertising policy compliance in AIJCR requires that all pharmaceutical company advertising and medical device advertising content conform to applicable Indian regulations, which means the Uniform Code for Pharmaceutical Marketing Practices — UCPMP — is the governing framework for drug promotion, alongside the Drugs and Magic Remedies Act provisions that restrict certain categories of therapeutic claims. Journal advertising ethics India is a topic that has received increasing regulatory attention, and Jaypee Brothers Medical Publishers, as a responsible publisher, requires that advertisers submit copy that has been reviewed and approved through their internal medical-legal process before submission. Advertisements making specific efficacy claims must be supported by data, and claims that are not consistent with approved prescribing information will not be accepted.

What we tell our clients — particularly those newer to medical journal advertising India — is that the compliance requirements, while occasionally frustrating from a creative standpoint, are actually a quality filter that protects your brand. An advertisement that runs in an indexed medical journal like AIJCR has, by definition, passed a credibility threshold that no social media post or digital banner can claim; the peer-reviewed journal context lends authority to your brand, but only if your advertising content meets the standard that context demands. At SmartAds, we have developed a pre-submission review process for medical journal advertising clients that flags potential compliance issues before material reaches the publisher, which has saved several clients from costly revisions and missed issue deadlines.

How Do You Book and Submit an Advertisement in AIJCR?

Booking an advertisement in the international journal clinical rhinology begins with a conversation with the commercial team at Jaypee Brothers Medical Publishers, whose offices are based in New Delhi, India. The Jaypee journals advertisement booking process is more straightforward than many first-time advertisers expect — you contact the publisher's advertising department, confirm position availability for the issue you are targeting, agree on journal advertising rates, and receive a booking confirmation along with the artwork specifications and submission deadline. The lead time for print placements is typically somewhere in the range of four to six weeks before the publication date, which means that for a tri-annual publication, the windows for booking are relatively narrow and should be planned well in advance.

Artwork for print advertising medical journal placements must be supplied as high-resolution PDF or TIFF files in CMYK colour mode, with bleed and trim marks included as per Jaypee's specifications; RGB files submitted for print will be converted, which can result in colour shifts that affect the appearance of your creative, so this is a detail worth getting right at the source. For digital advertising journal placements on JaypeeDigital, the specifications differ — banner ad journal units are typically supplied as JPEG or GIF files with dimensions and file size limits that the publisher's digital team will specify upon booking. We have found that clients who engage with the technical specifications early in the creative production process avoid the last-minute scrambles that can compromise both the quality of the advertisement and the relationship with the publisher.

One practical tip that our media planning team at SmartAds always shares: because the international journal clinical rhinology is a tri-annual publication, the competition for premium positions — particularly the back cover advertisement and inside front cover ad — can be significant among pharmaceutical companies active in the ENT and allergy space. Booking early, ideally at the start of the calendar year for all three issues, gives you first right of refusal on the positions that matter most and often unlocks better rates through an annual commitment. This is a straightforward negotiation that experienced media buyers handle routinely, but it requires the kind of publisher relationship and market knowledge that an agency with dedicated medical journal advertising experience brings to the table.

Can You Sponsor a Supplement or Issue of Clinical Rhinology Journal?

Sponsored supplements are among the most powerful — and most misunderstood — tools in the medical journal advertising toolkit. A sponsored supplement to the international journal clinical rhinology is a separately bound section, typically distributed alongside a regular issue, which is funded by a pharmaceutical company or medical device company but produced under the editorial oversight of AIRS and Jaypee Brothers Medical Publishers. The distinction between a supplement and a standard advertisement is significant: a supplement can contain symposium proceedings, expert roundtable discussions, clinical review articles, or treatment guidelines that provide genuine educational value to readers, which gives the sponsoring brand a depth of association with clinical thought leadership that a single page advertisement cannot achieve.

Journal reprint services are a related option that deserves consideration alongside supplement sponsorship. When a clinical study favourable to your product is published in the international journal clinical rhinology or another indexed medical journal, the ability to commission high-quality reprints — produced by Jaypee Brothers Medical Publishers to the same standard as the original journal — gives your field force a credible leave-behind piece that carries the weight of peer-reviewed publication. Reprints are governed by the same editorial independence principles as the journal itself; the content cannot be altered, which is precisely what makes them credible in the hands of a medical representative presenting to an ENT surgeon. We have seen pharmaceutical clients use reprints as the centrepiece of product launch medical journal campaigns with considerable success.

Bulk subscription arrangements are another mechanism through which brands can support the journal while building goodwill with the AIRS membership; a pharmaceutical company advertising in AIJCR that also sponsors bulk subscriptions for postgraduate ENT India departments at medical colleges is, in effect, ensuring that the next generation of rhinologists encounters both the journal's scientific content and the brand's advertising in a context that associates the two. This is a longer-term brand visibility doctors India strategy rather than a short-term sales driver, but in our experience, it is the kind of investment that compounds over time in ways that are difficult to replicate through other channels.

How Does AIJCR Advertising Connect to RHINOCON Annual Conference?

RHINOCON — the Annual Conference of the All India Rhinology Society — is the single most important gathering of rhinologists and ENT specialists in India, and its relationship with the international journal clinical rhinology creates a natural 360-degree marketing opportunity that very few brands are currently exploiting to its full potential. RHINOCON conference sponsorship and AIJCR journal advertising are, in the most practical sense, two touchpoints with the same audience — AIRS members who read the journal and attend the conference — which means that a brand present in both contexts builds a frequency of exposure that either channel alone cannot deliver. Rhinocon 2026 is scheduled to be held in Guwahati, Assam, which makes it an opportunity to reach ENT specialists from the northeastern region of India alongside the national AIRS membership.

The conference sponsorship options at RHINOCON typically include exhibition stalls, symposium sponsorships, workshop partnerships, and branding across conference materials — all of which complement a journal advertising presence by providing face-to-face and experiential touchpoints that reinforce the brand recognition built through print and digital advertising in AIJCR. One medical device advertising client we worked with combined a back cover advertisement in the international journal clinical rhinology across two issues with a workshop sponsorship at RHINOCON; the field team reported that delegates were already familiar with the product from the journal, which dramatically shortened the conversation at the exhibition stall and accelerated the path to clinical evaluation. That kind of synergy between print media and live events is something we actively design for at SmartAds rather than treating the two channels as separate decisions.

The practical implication for media planners is that the RHINOCON conference calendar should be mapped against the AIJCR publication schedule when planning an annual ENT marketing campaign; ideally, a full page advertisement or inside front cover ad in the issue immediately preceding the conference creates a priming effect, so that delegates arriving at RHINOCON are already carrying a mental impression of your brand from their reading. This sequencing is something that our media planning team at SmartAds builds into campaign timelines as standard practice for any client with a meaningful presence in the rhinology or ENT space — and it is a level of strategic integration that most brands are not currently achieving.

How Does Advertising in AIJCR Compare to Other ENT and Rhinology Journals in India?

The landscape of rhinology journal India and ENT journal advertising options is more varied than most advertisers realise, and the choice between them should be driven by audience specificity, indexing credentials, and the nature of the brand's clinical message. The international journal clinical rhinology, as the official publication of AIRS, has a uniquely strong claim on the Indian rhinology specialist audience; its Embase indexing and Scopus presence give it credibility among researchers and clinicians who use indexed medical journal status as a proxy for scientific quality. By comparison, some Medknow / Wolters Kluwer India ENT publications have broader otolaryngology scope, which may be appropriate for brands whose indication covers the full ENT spectrum but is less targeted for rhinology-specific products.

International journals — Rhinology from the International Rhinologic Society, Rhinology Online from the European Rhinologic Society, and the Journal of Otolaryngology and Rhinology from ClinMed — offer global reach and prestigious indexing, but their readership is predominantly outside India, which means that an advertiser focused on the Indian market is paying for global distribution while only needing Indian HCP outreach. The American Rhinologic Society's publications face a similar geographic mismatch for India-focused campaigns. The AIJCR, by contrast, is specifically calibrated for the Indian rhinology community, which means that the journal advertising rates, while competitive, are being applied against a highly relevant audience rather than diluted across geographies where your sales force does not operate.

To be fair, there are scenarios where advertising in both AIJCR and an international rhinology journal makes sense — particularly for multinational pharmaceutical companies running global campaigns where Indian market presence is one component of a broader strategy, or for brands seeking to build credibility with Indian rhinologists who are themselves active in international research networks. But for the majority of pharma advertising India campaigns targeting ENT specialists for products with Indian regulatory approval and domestic sales objectives, the international journal clinical rhinology offers the most direct and cost-effective route to the relevant prescribing audience.

What Is the ROI of Advertising in Indian Specialty Medical Journals?

The ROI question is the one that comes up in almost every media planning conversation we have with pharmaceutical marketing teams, and the honest answer is that medical journal advertising ROI is real but operates on a different timeline and mechanism than digital performance marketing. Research into prescribing behavior influence — including studies referenced in ICMJE-aligned publications — consistently shows that physicians who encounter a product in a peer-reviewed journal context demonstrate higher recall and more favourable attitudes toward that product than those who encounter it through promotional channels alone; the effect is not immediate, but it is durable in a way that a digital impression is not. Rhinology advertising ROI, specifically, benefits from the concentrated nature of the audience — there are not hundreds of thousands of rhinologists in India, which means that meaningful reach within the specialty is achievable at a scale that does not require mass-media budgets.

One way we help clients think about this at SmartAds is by calculating the cost per verified specialist contact rather than the raw CPM. When a full page advertisement in the international journal clinical rhinology reaches, say, several thousand AIRS members and journal subscribers — all of whom are verified healthcare professionals with a clinical interest in rhinology — the cost per contact works out to a figure that is genuinely competitive with HCP-targeted digital advertising, which carries the additional uncertainty of audience verification. The Dentsu e4m Report on Indian media has noted the growing importance of precision targeting in healthcare marketing, and specialty medical journal advertising is, in many ways, the original precision targeting — long before programmatic algorithms existed, journal advertising was reaching the exact specialists who needed to know about a product.

A retail pharmaceutical client we worked with — actually a mid-sized Indian pharma company with a nasal allergy portfolio — ran a six-issue campaign across two Indian rhinology and ENT journals, combined with RHINOCON conference sponsorship, and tracked field force feedback on brand awareness among ENT specialists over the campaign period; the improvement in unprompted brand recall among specialists in the cities where the field force was most active was substantial enough that the marketing director extended the campaign for a second year, which is, in our experience, the most reliable indicator that a media investment is delivering genuine value. Product launch medical journal campaigns, in particular, benefit from the credibility halo that indexed medical journal placement provides — it signals to clinicians that the brand is serious about the science, not just the sales pitch.

Frequently Asked Questions About Advertising in the International Journal Clinical Rhinology

Q: What is the International Journal Clinical Rhinology (AIJCR) and who manages it in India?

The international journal clinical rhinology — formally An International Journal Clinical Rhinology — is the official peer-reviewed publication of the All India Rhinology Society (AIRS), which is the national professional body for rhinologists and ENT specialists in India. The journal is published by Jaypee Brothers Medical Publishers (P) Ltd, headquartered in New Delhi, India, and is available both in print (ISSN 0974-4630) and online through the JaypeeDigital platform (eISSN 0975-6965). It is a tri-annual publication, appearing three times per year, and is indexed in Embase and Scopus, which are the indexing credentials that matter most to the Indian medical research community. Editorial governance rests with AIRS, while commercial operations — including advertising — are managed through Jaypee Brothers Medical Publishers' dedicated publishing team.

Q: How can pharma or medical device companies advertise in the International Journal Clinical Rhinology?

Pharmaceutical company advertising and medical device advertising in AIJCR is booked through the commercial advertising department at Jaypee Brothers Medical Publishers in New Delhi, India. The process involves confirming position availability for the target issue, agreeing on journal advertising rates, and submitting artwork that meets the publisher's technical specifications and passes advertising policy compliance review. All advertising content must conform to UCPMP guidelines for pharmaceutical promotion and must not make claims inconsistent with approved prescribing information; Jaypee Brothers Medical Publishers reviews all submitted copy before acceptance. Working with an experienced medical media agency — one that understands both the booking process and the compliance requirements — significantly reduces the friction involved in getting an advertisement placed correctly and on time.

Q: What print advertisement formats are available in the AIJCR magazine?

The print advertising options in the international journal clinical rhinology include the back cover advertisement, which is the most premium position and commands the highest rate; the inside front cover ad, which is the second-most-prominent position; full page advertisements placed within the body of the journal; and half page advertisement options for brands working with smaller budgets or more focused creative concepts. All print advertising is produced in CMYK colour, and artwork must be submitted as high-resolution PDF or TIFF files with appropriate bleed and trim marks. The publisher provides detailed technical specifications upon booking confirmation, and lead times for artwork submission are typically four to six weeks before the publication date.

Q: Does the International Journal Clinical Rhinology accept digital or online advertisements?

Yes — the international journal clinical rhinology offers digital advertising options through the JaypeeDigital platform, which hosts the full text of the journal online. Digital advertising journal placements include banner ad journal units that appear alongside article pages, which means your advertisement is served to readers who are actively engaged with rhinology research content. The e-TOC alert advertising option — where a sponsored message is included in the electronic Table of Contents alert sent to subscribers when a new issue is published — is a particularly targeted digital touchpoint, reaching verified healthcare professionals at the moment of maximum clinical engagement. Digital ad specifications vary from print and are provided by Jaypee Brothers' digital publishing team upon enquiry.

Q: What are the advertising rates for the Clinical Rhinology journal in India?

Jaypee Brothers Medical Publishers does not publish a publicly available rate card for AIJCR advertising, which is common practice among Indian specialty medical journals; journal advertising rates are provided upon direct enquiry to the publisher's commercial team. From our experience at SmartAds managing medical journal advertising bookings, rates for a full page advertisement in a comparable Indian specialty journal are typically in the ballpark of ₹50,000 to ₹1,50,000 per insertion depending on position and colour, with premium positions like the back cover advertisement and inside front cover ad commanding rates toward the higher end of that range. Multi-issue and annual booking packages typically attract negotiated discounts, and it is worth noting that GST at the applicable rate is charged on top of the base advertising rate for all commercial placements in Indian publications.

Q: How far in advance must advertisement material be submitted to AIJCR?

The standard lead time for print advertising material submission to the international journal clinical rhinology is approximately four to six weeks before the publication date of the target issue. Given that AIJCR is a tri-annual publication with three issues per year, the booking windows are relatively defined, and late submissions risk missing the issue entirely — which, in a publication with only three issues annually, means a delay of several months before the next opportunity. For digital advertising journal placements, lead times may be shorter, but it is advisable to confirm exact deadlines with Jaypee Brothers Medical Publishers at the time of booking. Our recommendation at SmartAds is always to book at least eight weeks in advance to allow adequate time for artwork production, compliance review, and any revisions required by the publisher.

Q: Who reads the International Journal Clinical Rhinology in India?

The primary readership of AIJCR consists of AIRS members — practising rhinologists, ENT surgeons with subspecialty interest in nasal and sinus conditions, skull base surgery specialists, and otolaryngology faculty at Indian medical colleges. The journal also reaches postgraduate ENT India trainees who are completing their DNB or MS in otolaryngology, as well as allied healthcare professionals and medical device procurement officers in ENT departments. Geographically, the readership is concentrated in major metros but extends to tier-2 cities through Jaypee Brothers Medical Publishers' national distribution network. For any brand seeking to advertise to doctors India in the rhinology and nasal surgery space, this readership profile represents a highly targeted and clinically relevant audience.

Q: What advertising policies and eligibility rules apply to AIJCR?

Advertising in the international journal clinical rhinology must comply with ICMJE guidelines on the separation of advertising from editorial content, UCPMP guidelines governing pharmaceutical company advertising in India, and the Drugs and Magic Remedies Act provisions restricting certain therapeutic claims. The journal maintains strict editorial independence, meaning that advertising placement has no influence on editorial decisions, and Jaypee Brothers Medical Publishers reserves the right to reject any advertisement that does not meet content standards or that conflicts with the journal's scientific integrity. Advertisers are required to submit copy that has been approved through their internal medical-legal review process, and claims must be consistent with approved prescribing information or device indications. Journal advertising ethics India is taken seriously by both the publisher and AIRS, and brands that approach the process with appropriate rigour will find the compliance requirements manageable.

Q: Can I sponsor a supplement issue of the Clinical Rhinology journal?

Yes — sponsored supplements are available through Jaypee Brothers Medical Publishers and represent one of the most impactful formats in clinical rhinology journal advertising. A sponsored supplement is a separately bound section distributed with a regular issue of the international journal clinical rhinology, funded by a sponsor but produced under AIRS editorial oversight; it can contain symposium proceedings, expert roundtable discussions, clinical reviews, or treatment guidelines that provide genuine educational value to readers. The sponsoring brand is acknowledged but does not control the editorial content, which is precisely what gives the supplement its credibility with the AIJCR readership. Journal reprint services and bulk subscription arrangements are also available through Jaypee Brothers for brands seeking additional ways to extend their association with the journal.

Q: Is GST applicable on medical journal advertising in India?

Yes — GST is applicable on advertising placements in Indian publications, including medical journal advertising in AIJCR. Advertising services in India attract GST at 18%, which is charged on top of the base journal advertising rates agreed with Jaypee Brothers Medical Publishers. This is a standard commercial consideration for all magazine advertising India bookings and should be factored into budget planning from the outset. For pharmaceutical companies and medical device companies that are GST-registered, the input tax credit mechanism may allow partial recovery of the GST paid on advertising expenditure, subject to the specific tax treatment applicable to their business — a detail worth confirming with your finance team before finalising the advertising budget.

Q: How does advertising in AIJCR compare to other ENT and rhinology journals in India?

The international journal clinical rhinology offers the most direct access to the Indian rhinology specialist audience among available journal options, by virtue of its status as the official AIRS publication and its Embase and Scopus indexing. Medknow / Wolters Kluwer India ENT journals have broader otolaryngology scope, which may suit brands with wider ENT indications but is less targeted for rhinology-specific products. International journals such as Rhinology and Rhinology Online offer global reach but are not calibrated for the Indian market, making them less efficient for pharma advertising India campaigns focused on domestic HCP outreach. For brands specifically targeting rhinologists and nasal surgery specialists in India, AIJCR is the most direct and cost-effective channel available in the indexed medical journal category.

Q: Can I advertise in AIJCR and also sponsor the RHINOCON annual conference for wider ENT outreach?

Absolutely — and this is, in our view, the optimal strategy for any brand seeking meaningful brand visibility doctors India in the rhinology space. RHINOCON conference sponsorship and AIJCR journal advertising reach the same core AIRS audience through complementary touchpoints; the journal builds awareness and credibility over time, while conference sponsorship provides face-to-face engagement and product experience opportunities. Rhinocon 2026 in Guwahati, Assam offers a specific opportunity to reach ENT specialists from the northeastern region alongside the national AIRS membership. Sequencing a full page advertisement or inside front cover ad in the AIJCR issue preceding the conference creates a priming effect that meaningfully improves the quality of delegate interactions at the conference — a strategy that our SmartAds media planning team builds into ENT campaign timelines as standard practice.

Q: What is the ROI of advertising in indexed Indian medical journals like AIJCR?

The ROI of clinical rhinology journal advertising operates through mechanisms that differ from direct-response digital advertising but are well-documented in the medical marketing literature. Peer-reviewed journal context has been shown to enhance brand recall, improve physician attitudes toward advertised products, and positively influence prescribing behavior over time — effects that are particularly durable in specialist audiences who engage with journal content as part of their ongoing professional development. The cost per verified specialist contact in an indexed medical journal like AIJCR is competitive with HCP-targeted digital channels, with the additional advantage that journal readers are verified healthcare professionals rather than algorithmically targeted digital users whose professional status cannot be confirmed. For product launch medical journal campaigns and sustained brand-building in the ENT space, the rhinology advertising ROI case is strong when evaluated over a 12-to